Ankyloblepharon

From WikiMD's WELLNESSPEDIA


Ankyloblepharon
Synonyms
Pronounce N/A
Specialty N/A
Symptoms Partial or complete fusion of the eyelids
Complications
Onset Congenital or acquired
Duration
Types
Causes Genetic mutations, trauma, infections
Risks
Diagnosis Clinical examination
Differential diagnosis Blepharitis, Ectropion, Entropion
Prevention
Treatment Surgical separation of eyelids
Medication
Prognosis Generally good with treatment
Frequency Rare
Deaths


Ankyloblepharon is a medical condition characterized by the partial or complete fusion of the eyelids to each other. This condition can be congenital or acquired and may affect one or both eyes.

Classification[edit]

Ankyloblepharon can be classified into two main types:

  • Congenital Ankyloblepharon: This type is present at birth and is often associated with other congenital anomalies.
  • Acquired Ankyloblepharon: This type develops later in life due to trauma, infection, or inflammatory diseases.

Causes[edit]

The causes of ankyloblepharon can vary depending on whether it is congenital or acquired:

Symptoms[edit]

The primary symptom of ankyloblepharon is the fusion of the eyelids, which can lead to:

  • Impaired vision
  • Difficulty in opening the eyes
  • Discomfort or pain
  • Increased risk of eye infections

Diagnosis[edit]

Diagnosis of ankyloblepharon is typically made through a clinical examination by an ophthalmologist. Additional tests may include:

Treatment[edit]

Treatment for ankyloblepharon depends on the severity and underlying cause:

  • Surgical Intervention: Separation of the fused eyelids through a surgical procedure.
  • Medical Management: Use of antibiotics or anti-inflammatory medications if the condition is due to an infection or inflammation.

Prognosis[edit]

The prognosis for individuals with ankyloblepharon varies. Early diagnosis and appropriate treatment can lead to a good outcome, although some cases may require ongoing management to prevent recurrence.

See Also[edit]

References[edit]

External Links[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.